In addition, the lack of expression of PD-1 in CD8 T cells in newly diagnosed MM patients could also explain the lack of efficacy of the disruption of PD-1/PDL-1 interaction, being TIGIT the most frequent immune checkpoint receptor expressed on T cells [100]. Here, CD8A is linked to Miyoshi myopathy.